Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells by Marsland, B. J. et al.
Bystander suppression of allergic airway
inflammation by lung resident memory CD8 T cells
Benjamin J. Marsland*†‡, Nicola L. Harris*, Mali Camberis*, Manfred Kopf†, Sarah M. Hook*, and Graham Le Gros*
*Malaghan Institute of Medical Research, Wellington School of Medicine, 6002 Wellington, New Zealand; †Molecular Biomedicine, Swiss Federal Institute of
Technology, Wagistrasse 27, Schlieren-Zurich 8952, Switzerland
Communicated by William E. Paul, National Institutes of Health, Bethesda, MD, March 5, 2004 (received for review September 30, 2003)
CD8 memory T cells have recently been recognized as playing a
key role in natural immunity against unrelated viral infections, a
phenomenon referred to as ‘‘heterologous antiviral immunity.’’
We now provide data that the cellular immunological interactions
that underlie such heterologous immunity can play an equally
important role in regulating T helper 2 immune responses and
protecting mucosal surfaces from allergen-induced inflammation.
Our data show that CD8 T cells, either retained in the lung after
infection with influenza virus, or adoptively transferred via the
intranasal route can suppress allergic airway inflammation. The
suppression is mediated by IFN-, which acts to reduce the acti-
vation level, T helper 2 cytokine production, airways hyperrespon-
siveness, and migration of allergen-specific CD4 T cells into the
lung, whereas the systemic and draining lymph node responses
remain unchanged. Of note, adoptive transfer of previously acti-
vated transgenic CD8 T cells conferred protection against allergic
airway inflammation, even in the absence of specific-antigen.
Airway resident CD8 T cells produced IFN- when directly ex-
posed to conditioned media from activated dendritic cells or the
proinflammatory cytokines IL-12 and IL-18. Taken together these
data indicate that effectormemory CD8 T cells present in the
airways produce IFN- after inflammatory stimuli, independent of
specific-antigen, and as a consequence play a key role in modifying
the degree and frequency of allergic responses in the lung.
Recent investigations have shown that memory CD8 T cellsare retained in peripheral tissues for long periods after
infection (1, 2). It is normally hypothesized that these memory
T cells allow the host to respond efficiently to subsequent
infections against the same virus; however, Chen et al. (3) have
identified a secondary role for these CD8 T cells as demon-
strated by their activation and contribution to protective immu-
nity against unrelated viral infections. The term ‘‘heterologous
antiviral immunity’’ is used to describe this phenomenon. In-
triguingly, it has long been known that viral infections have the
potential to influence unrelated immune responses for better or
worse. Experimental and epidemiological data show that infec-
tion of asthmatic individuals with respiratory viruses (4) such as
influenza A (5) and respiratory syncytial virus (6) can greatly
exacerbate the development and pathology of asthma. However,
in international epidemiological studies of exposure rates, the
indication is that some types of infection may actually decrease
the prevalence of asthma (7–9). The term ‘‘hygiene hypothesis’’
was coined (10) to describe the inverse relationship between
decreased incidence of diseases such as tuberculosis (11) and
asthma. It was suggested that the removal of such diseases in the
western world removed a key immunoregulatory influence,
which has led to the increased incidence of allergic airway
disease. The precise nature of these immunoregulatory influ-
ence(s) has remained elusive, although experimental investiga-
tions have identified the inflammatory cytokine IFN- as an
important mediator of the phenomenon (12).
We hypothesized that viral infections, which stimulate the
conditions for heterologous immunity, may have the potential to
influence the cellular processes involved in the development of
allergen-induced airway inflammation. In particular, we inves-
tigated the effect of previous influenza A virus infection on the
development of allergic airway inflammation in mice.
We report here that local production of IFN- by CD8 T
cells, either resident in the airways after influenza infection, or
specifically adoptively transferred into the airways, can regulate
allergic immune responses. Specifically, effectormemory
CD8 T cells reduce the activation status and suppress the
migration of allergen-specific CD4T cells into the airways. The
consequence of this immunomodulation is reduced eosinophil
migration, airways hyperresponsiveness, and T helper 2 (Th2)
cytokine production. This work identifies a key mechanism
whereby CD8 T cells, which underpin heterologous antiviral
immunity, may have the equally important role of regulating the
development of allergic immune responses in the lung and
preventing the development of asthma. In addition, our intra-
nasal (i.n.) adoptive transfer study demonstrates that localization
of effectormemory cells in the lung and airways is a powerful
regulator of local responses and should be considered in future
vaccine design and cell therapy.
Materials and Methods
Mice. C57BL6J mice were originally obtained from The Jackson
Laboratory. Strain 318 mice, transgenic for a T cell antigen
receptor (TCR) specific for H-2 Db plus fragment 33–41 of the
lymphocytic choriomeningitis virus glycoprotein (LCMV33–41)
were kindly provided by H. Pircher (University of Freiburg,
Freiburg, Germany). Breeding of all mice was carried out at the
Biomedical Research Unit of the Wellington School of Medi-
cine. All animal experimental procedures were approved by the
Wellington School of Medicine Animal Ethics Committee and
conducted in accordance with the guidelines of the University of
Otago (Dunedin, New Zealand).
Infection with Influenza Virus. On day 0 mice were anesthetized by
i.p. injection of a mixture of ketamine and xylazine (Phoenix,
Auckland, New Zealand), and 12 hemagglutinating units of
AHKx31 (H3N2) influenza A virus, in a 30-l volume of PBS,
was administered by i.n. inoculation.
Purification of Nippostrongylus brasiliensis-Derived Allergen (NES).
L3 infective larvae were washed in sterile PBS and then washed
several more times in an antibiotic mixture [RPMI medium
16401/20 penicillin–streptomycin1/100 gentamycin (GIBCO
BRL)]. The worms were then cultured in medium (RPMI
medium 16401/100 penicillin–streptomycin1/100 gentamycin)
supplemented with 1% glucose at 37°C for 48 h. The supernatant
was concentrated and amount of protein NES determined by
absorbance at 280 nm.
Abbreviations: NES, Nippostrongylus brasiliensis-derived allergen; TCR, T cell antigen
receptor; BAL, bronchoalveolar lavage; LPS, lipopolysaccharide; i.n., intranasal; DC, den-
dritic cell; Th2, T helper 2; IMDM, Iscove’s modified Dulbecco’s medium.
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NES-Induced Airway Inflammation. Mice were injected i.p. with 0.2
g of NES in 200 l of alum adjuvant (Serva) 14 days after
influenza- or mock-infection. Then 7 days later mice were
anesthetized, and 5 g of NES in a 50-l volume of PBS was
administered i.n.
Quantitative and Qualitative Measurement of Inflammatory Cells in
the Bronchoalveolar Lavage (BAL). At 4 days after i.n. challenge
with NES, mice were killed with a lethal dose of anesthetic, and
BAL was performed as described (13).
Histological Analysis. Lungs were fixed in 10% phosphate-
buffered formalin for 24 h and embedded in paraffin wax.
Sections were cut and stained with hematoxylin and eosin by
using standard histological protocols.
Measurement of Airway Responsiveness. On day 4 after i.n. chal-
lenge with NES, mice were placed in individual unrestrained
whole body plethysmograph chambers (Buxco Electronics, Pe-
tersfield, U.K.). Airway responsiveness was assessed in mice by
inducing airf low obstruction with aerosolized methylcholine-
chloride and enhanced pause (PenH) measured by using BIO-
SYSTEM XA software (Buxco Electronics, Sharon, CT).
Serum IgE ELISA. A sandwich ELISA was used to measure total
IgE levels in the serum as described (12).
Fluorescence-Activated Cell Sorter Analysis. Anti-CD44-phyco-
erythrin (PE), anti-CD62L-PE, anti-CD69-PE, anti-IFN--PE,
and anti-IL-4-FITC Abs were obtained from Pharmingen. Anti-
CD8 (2.43) and anti-CD4 (GK1.5) (kindly provided by Fred
Finkelman, Cincinnati Veterans Affairs Medical Center, Cin-
cinnati) were affinity-purified from hybridoma culture super-
natants. Flow cytometric analysis was performed on a FACSort
(Becton Dickinson).
Intracellular Cytokine Staining. Intracellular staining was per-
formed as described (13).
In Vivo IFN- Neutralization. At 14 days after influenza- or mock-
infection, mice were injected with 0.5 mg of anti-IFN- (XMG-
D6, kindly provided by Fred Finkelman) i.p. for 3 consecutive
days and then again every third day until the mice were killed.
Anti-IFN- Ab was affinity-purified from hybridoma culture
supernatants as described above.
Preparation of CD8 T Cells for Adoptive Transfer. Spleens from
L318 transgenic mice were removed, homogenized into a single
cell suspension, and lysed to remove RBCs. Cells were resus-
pended at 1  106ml in 1 ml of Iscove’s modified Dulbecco’s
medium (IMDM) (Sigma–Aldrich) and dispensed into 24-well
plates (Falcon) previously coated with 10 gml anti-CD3.
IMDM (1 ml) containing 10 unitsml IL-2 and 10 ngml IL-6
(x63J-mIL6) was added to each well. Cells were incubated for 5
days and cytokines replenished on days 2 and 4 by replacing 1 ml
of media per well. On day 5 cells were harvested and cultured in
24-well plates containing 10 unitsml IL-2, with replacement of
Fig. 1. A population of CD8 T cells with an effectormemory phenotype remain in the airways after influenza virus infection. After influenza infection (25
days), BAL was performed on naive and previously infected mice. (a) Total CD8 T cell numbers in pooled samples were determined by flow cytometry. (b) Pooled
BAL cells were stimulated at 37°C by anti-CD3 in the presence of IL-2 and anti-CD28 for a total of 6 h. IFN- production by CD8 T cells was determined by flow
cytometry. (c) Surface expression of CD44, CD62L, and CD69 was determined for gated CD8 cells in the postinfection group by flow cytometry. CD8 T cells
from pooled peripheral lymph nodes were used as naive controls. Insufficient cells were present in the airways of naive mice to measure IFN- production or
surface marker staining. The data shown are from independent experiments using three to five mice per group. Each experiment was repeated three times with
similar results. Values are representative of individual mice.
Fig. 2. Allergen-induced migration of eosinophils into the airways is reduced
in mice previously infected with influenza virus. Mice were infected i.n. with
influenza virus or mock-infected with PBS. Groups were sensitized i.p. (14 days
later) with 0.2 g of NES in alum adjuvant followed by an i.n. challenge of
5 g of NES in PBS 7 days later. (a) Infiltration of inflammatory cells into
the airways was determined by differential cell counts of total BAL cells. (b)
Hematoxylineosin staining of formalin-fixed, paraffin-embedded tissue 4
days after i.n. NES challenge. (c) After NES challenge (4 days), mice were
exposed to increasing doses of nebulized methylcholine, and airway hyper-
responsiveness was measured in an unrestrained whole body plethysmo-
graph. All data shown are from representative experiments using three to five
mice per group. These experiments were repeated with similar results. *, P
0.03, as determined by the Student t test between the PBSNES and FLUNES
groups.
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IL-2 after 24 h. Cells were washed in IMDM before use and
determined to be 80% CD8 by flow cytometry.
Preparation of Dendritic Cell (DC) Supernatant. Bone marrow cells
from C57BL6J mice were cultured in six-well plates (Falcon) at
4  105 cells per ml in IMDM (Sigma-Aldrich) containing 20
ngml IL-4 and 20 ngml granulocytemacrophage colony-
stimulating factor, as described (14). Cultures were provided
with fresh IMDM and cytokines every 2 days and incubated at
37°C for a total of 7 days. Lipopolysaccharide (LPS, 100 ngml)
from Sigma was added to the media 16 h before harvest. The
supernatant was removed, filtered, and stored at 20°C until
required.
Activation of BAL Lymphocytes with Conditioned Media. Approxi-
mately 5  105 BAL cells were immediately fixed ex vivo in 4%
paraformaldehyde, and the remaining BAL cells were incubated
at 37°C for 2 h to remove macrophages. Floating lymphocytes
were resuspended at 5  105 cells per ml in either DC super-
natant or media supplemented with 100 ngml IL-18 (Pepro-
Tech, Rocky Hill, NJ) andor 10 ngml IL-12 (PeproTech).
These cells were then plated in 24-well plates (Falcon) at 5 105
cells per well and incubated overnight at 37°C. Monensin
(Calbiochem–Novabiochem) was added in the last 2 h of the
culture.
Statistics. Statistical significance was analyzed by the Student t
test. Unless otherwise indicated, data represent mean SD, with
statistical significance defined at P  0.05.
Results and Discussion
Memory CD8 T Cells Remain in the Airways After Influenza Infection.
We extensively analyzed the cell types present in the airways of
naive mice and compared them to cell types found in the airways
of mice that had recovered from an infection with influenza
virus. In our model of experimental influenza infection, infec-
tious virions were cleared within 7–9 days, and the primary
immune response subsided within 14 days (data not shown).
Negligible numbers of haemopoietic cells (2  104 total cells
per BAL) were found in the airways of naive mice and were
comprised of predominantly alveolar macrophages. In striking
contrast, a significant population of CD8 T cells could still be
detected in the airways of mice 25 days after infection with
influenza virus (Fig. 1a) and remained for 100 days (data not
shown). A large proportion of the CD8 T cells isolated from
the airways at day 25 after infection had the potential to produce
IFN- after 6-h restimulation on anti-CD3, as shown by intra-
cellular staining (Fig. 1b). Furthermore, these cells expressed
high levels of CD44 and low levels CD62L and CD69 (Fig. 1c),
had a small resting size as determined by flow cytometry, and
specifically lysed influenza-peptide-pulsed target cells after ex
vivo activation with plate-bound anti-CD3 (data not shown).
Together these data indicated that after the resolution of
influenza virus infection, a population of influenza-specific
CD8 memory T cells resided in the airways. These data are
supported by recent studies showing that virus-specific CD8 T
cells reside for long periods in both lymphoid and nonlymphoid
tissues (1). Moreover, studies by Hogan et al. (15) identified a
Fig. 3. Previous infection with influenza virus reduces CD4 T cell migration into and activation within the airways. Mice were infected i.n. with influenza virus
or mock-infected with PBS. Both groups were sensitized i.p. (14 days later) with 0.2 g of NES in alum adjuvant followed by an i.n. challenge of 5 g of NES in
PBS 7 days later. (a) The numbers of CD4 T cells infiltrating the airways was determined by flow cytometric analysis of pooled BAL cells taken from mice 4 days
after i.n. NES challenge. (b) The expression of CD44 and CD62L on gated CD4 T cells from pooled BAL and mediastinal lymph node samples was determined
by flow cytometry. The numerical indices represent the geometric mean of the fluorescence intensity for each sample. (c) Total IgE levels in the serum of mice
that had been sensitized and challenged to NES, with or without previous influenza infection, was measured by ELISA. Serum IgE in mice that had not been
sensitized and challenged to NES was below the limit of detection. (d) Airway lymphocytes were stimulated for 6 h with DCs pulsed with NES, and IL-4IFN-
production was determined by flow cytometry. All data shown are from representative experiments using four to six mice per group. Each experiment was
repeated with similar results.
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substantial population of antigen-specific T cells in the lung that
persisted for several months after recovery from an influenza
virus infection.
Previous Infection by Influenza Virus Suppresses the Induction of
Allergic Airway Inflammation. It has previously been shown that
memory CD8 T cells can inf luence the outcome of unrelated
viral infections (3); however it is unclear whether such memory
cells can inf luence the development of allergy. We tested
whether the presence of inf luenza-specific effectormemory
CD8 T cells could modify a subsequent allergen-induced,
Th2-dependent allergic immune response in the airways. After
inf luenza infection (14 days), mice were sensitized for a
subsequent Th2 immune response by i.p. immunization with
allergens extracted from NES absorbed on alum adjuvant.
Later (7 days) these sensitized mice were challenged i.n. with
NES in PBS, and subsequent airway inf lammation was ana-
lyzed. The i.n. challenge with NES induced substantial infil-
tration of lymphocytes and eosinophils into the airways with
the peak response occurring at day 4 (Fig. 2a and data not
shown). Mice that had previously been infected with inf luenza
showed a dramatic reduction in the degree of NES-induced
infiltration of eosinophils in both the airways (Fig. 2a) and the
lung parenchyma (Fig. 2b) in comparison to uninfected, but
similarly NES-challenged mice. We have found a comparable
suppression 100 days after infection and in addition have
tested other allergen models such as ovalbumin and found a
similar suppression after inf luenza infection (data not shown).
The hallmark feature of allergic asthma is airways hyperre-
sponsiveness, and accordingly, we sought to investigate
whether this IL-13-dependent response was also reduced after
inf luenza infection. In line with the reduced infiltration of
eosinophils, the response to increasing doses of methylcholine
was similarly reduced in mice which had previously been
infected with inf luenza (Fig. 2c). We have also investigated
whether the timing of allergen sensitization relative to the
infection was important and found that the outcome was
comparable irrespective of whether mice were sensitized be-
fore or after infection (data not shown). Taken together, these
data show that the presence of CD8 memory T cells in the
lung is associated with suppressed allergen-induced airway
inf lammation.
Previous Infection with Influenza Virus Reduces Allergen-Induced
CD4 T Cell Migration into, and Activation Within, the Airways.
Allergen-specific CD4 T cells producing IL-4 and IL-5 have
been demonstrated to be major inducers of airway eosinophilia
(16). In further support of this, consistently elevated numbers of
CD4 T cells have been found in BAL fluids and bronchial
biopsies from asthmatics (17). We therefore investigated the
effect of previous influenza infection on CD4 T cell migration,
activation state, and cytokine production in the airways. After
sensitization and challenge with NES, we found that mice
previously infected with influenza had reduced numbers of
CD4 T cells in the airways (Fig. 3a). Analysis of extended time
points confirmed that this result was not due to delayed entry of
CD4 T cells into the airways (data not shown). Furthermore,
the expression of CD44 on the CD4 T cells that migrated into
the airways was lower in comparison with uninfected but simi-
larly challenged control mice (Fig. 3b). Expression of CD62L was
comparable between groups (Fig. 3b). No such reduction in
CD44 expression was detected on CD4 T cells from the
draining lymph node (Fig. 3b), nor was there any change in
serum IgE levels (Fig. 3c). These data indicate that suppression
of allergen-specific CD4 T cell activation is limited to the lung
environment after influenza infection. These data were con-
firmed with two TCR-transgenic T cell adoptive transfer models
where specific T cells can be tracked in vivo by using mAbs
directed against the specific VV TCR chains (data not
shown).
To establish whether the CD4T cells in the airways exhibited
full Th2 effector function, we isolated lymphocytes from the
airways of mice previously infected with influenza or mock-
infected with PBS, and restimulated them for 6 h by using DCs
pulsed with NES. We found that NES-specific CD4 T cells
showed strong Th2 polarization as evidenced by a large propor-
tion of cells producing IL-4 (Fig. 3d). In striking contrast, a
reduced proportion of CD4 T cells isolated from the airways
of mice previously infected with influenza produced IL-4, and in
addition, a proportion of NES-specific cells producing IFN-
were also detected (Fig. 3d). Taken together with the reduced
total number of CD4 T cells detected in the airways after
influenza infection, overall Th2 cytokine production is reduced
even further. This reduction in Th2 cytokine production is
likely to be responsible for the previously observed reduc-
tion in eosinophil accumulation and development of airway
hyperresponsiveness.
IFN- Mediates the Influenza-Induced Inhibition of Allergic Airway
Inflammation. IFN- is produced in large quantities by CD8 T
cells during influenza virus infection (18). IFN- is also capable
of inhibiting the differentiation of in vitro-derived Th2 cells (19)
Fig. 4. Anti-IFN- treatment abrogates influenza-induced suppression of
eosinophil migration and CD44 expression on allergen-induced CD4 T cells
in the airways. Mice were infected i.n. with influenza virus or mock-infected
with PBS. All groups were sensitized i.p. (14 days later) with 0.2 g of NES in
alum adjuvant followed by an i.n. challenge of 5 g of NES in PBS 7 days later.
The anti-IFN- group received 0.5 mg of XMG-D6 Ab at days 14, 15, 16, 19, and
22 after infection. (a) Infiltration of eosinophils into the airways was measured
4 days after i.n. NES challenge. (b) Expression of CD44 on gated CD4 T cells
was determined by fluorescence-activated cell sorter analysis of pooled BAL
samples.Thenumerical indices represent thegeometricmeanofthefluorescence
intensity for each sample. The data shown are from representative experiments
using three to five mice per group. Each experiment was repeated with similar
results. Statistical significance (P  0.02) as determined by the Student t test
between the PBSNES and FLUNES groups is designated by *.
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and regulating Ab isotype switching (20). We therefore investi-
gated the role of IFN- during the influenza-induced suppres-
sion of CD4 T cell activation and consequent reduction of
allergic airway eosinophilia. For this purpose, IFN- activity was
neutralized by using in vivo mAb treatment 14 days after
infection and throughout NES-allergen sensitization and i.n.
challenge. Neutralization of IFN- restored NES-induced aller-
gic airway eosinophilia in mice previously infected with influ-
enza (Fig. 4a). We have previously found that IFN- neutral-
ization has no effect on the development of airway eosinophilia
in uninfected animals (data not shown). IFN- also plays a role
in the influenza-induced reduction of CD44 expression on
allergen-specific CD4 T cells, as this was partially restored in
anti-IFN- mAb-treated mice (Fig. 4b). These data strongly
indicate that IFN- plays a role in the reduction of Th2 immune
responses and airway eosinophilia in mice that had recovered
from previous influenza infection. A similar role for IFN- has
been shown by using a model in which bacillus Calmette–Gue´rin
infection resulted in a reduced allergic airway eosinophilia (12).
Adoptively Transferred In Vitro Cultured CD8 T Cells Are Capable of
Suppressing Allergic Airway Eosinophilia in an Antigen-Independent
but IFN--Dependent Manner. We sought to determine whether the
population of CD8 T cells resident in the airways of mice
previously infected with influenza virus was directly responsible
for the reduction in allergic airway eosinophilia. To this end, we
attempted to deplete CD8 T cells in vivo by using an anti-CD8
mAb depletion protocol. Anti-CD8 mAb treatment completely
removed CD8 T cells from lymphoid organs; however, deple-
tion of the memory CD8 T cell population in the airways was
not effective, even after using large doses of affinity purified
mAb (data not shown). We thus developed a model involving the
adoptive transfer of in vitro-activated CD8 T cells directly into
the airways as a means of investigating the potential of these cells
for inhibiting allergic airway eosinophilia. Firstly, C57BL6J
mice were sensitized with an i.p. injection of NES absorbed on
alum adjuvant. Six days later 5  105 in vitro-activated CD8 T
cells from LCMV33–41 TCR transgenic or LCMV33–41 TCR
transgenic IFN-/mice were administered via the i.n. route.
The following day, mice were challenged i.n. with NES, and 4
days later the infiltration of eosinophils was determined (Fig. 5).
Adoptive transfer of in vitro-activated CD8 T cells before i.n.
administration of NES suppressed the development of an airway
eosinophilia. This suppression depended on the action of IFN-
as the adoptive transfer of in vitro-activated CD8 IFN-/ T
cells failed to suppress the eosinophilia (Fig. 5). The adoptively
transferred CD8 T cells did not constitutively produce IFN-
(data not shown) and remarkably did not require in vivo expo-
sure to their specific antigen to mediate this suppression. Thus,
it was likely that these cells were induced to secrete IFN- after
nonspecific stimuli received after i.n. challenge with allergen.
Airway-Resident Effector Memory CD8 T Cells Can Be Activated to
Produce IFN- in the Absence of Specific Antigen. We observed that
airway resident CD8 T cells up-regulated surface expression of
CD69 during NES-induced airway inflammation, indicating
recent activation (Fig. 6a). Furthermore, CD8 T cells isolated
from the airways 6 h after i.n. NES challenge were found to
produce IFN- as shown by direct ex vivo intracellular cytokine
staining (Fig. 6b). To establish what factors were responsible for
this activation, we isolated airway resident CD8 T cells from
previously infected mice and analyzed them in vitro. It was
possible that the influenza-induced CD8 T cells were cross-
reactive with NES epitopes and were thus activated through
TCR signaling; however, because suppression of allergic airway
Fig. 5. Adoptive transfer of activated CD8IFN- T cells via the i.n. route
inhibits NES allergen-induced airway eosinophilia in an IFN--dependent
manner. Splenocytes from L318  IFN-/ or WT L318 mice were stimulated
in vitro with anti-CD3 in the presence of IL-2 and IL-6 for 5 days. The proportion
of CD8T cells present in each culture was determined by flow cytometry. PBS,
5 105 CD8 IFN-/ cells or 5 105 CD8 IFN-/ cells were administered
i.n. to C57BL6J mice previously sensitized i.p. with 0.2 g of NES in alum. At
1 days after adoptive transfer, mice were challenged i.n. with NES in PBS.
Infiltration of eosinophils into the airways was measured 4 days after NES
challenge by BAL. The data shown are from a representative experiment using
three to five mice per group. The experiment was repeated three times with
similar results. Statistical significance (P 0.02) as determined by the Student
t test between the PBS and CD8 IFN-/ groups is designated by *.
Fig. 6. Airway resident effector memory CD8 T cells can be stimulated to
produce IFN- in the absence of specific antigen. After influenza infection (14
days) mice were sensitized i.p. with 0.2 g of NES in alum adjuvant or alum
adjuvant alone, followed by i.n. challenge with 5g of NES in PBS or PBS alone
7 days later. (a) The surface expression of CD69 on CD8 T cells was deter-
mined by flow cytometry. (b) BAL was performed and lymphocytes were
isolated 6 h after NES i.n. challenge. IFN- cytokine production by CD8 T cells
was determined directly ex vivo by intracellular cytokine staining and flow
cytometry. (c) After influenza infection (25 days), airway resident lymphocytes
were isolated by BAL and samples pooled. These lymphocytes were then
cultured overnight in supernatant from unstimulated DCs, LPS-activated DCs,
or in media supplemented with IL-18 andor IL-12 overnight. IFN-production
by CD8 T cells was determined by flow cytometry. Numerical indices repre-
sent percentage of CD8 T cells producing IFN-. The data shown are from
representative experiments using three to five mice per group (a and b) or cells
from pooled BAL samples of 25 mice (c). Each experiment was repeated with
similar results.
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inflammation was also found when moth cytochrome C88–103 or
OVA323–339 peptides were used as allergens (data not shown), we
reasoned that these effector memory CD8 T cells may be
activated in the absence of specific antigen by inflammatory
cytokines. We thus isolated airway-resident lymphocytes 25 days
after influenza infection and analyzed the ability of various
stimuli and supernatant fractions to activate memory CD8 T
cells directly. For this purpose bone marrow-derived DCs were
cultured in vitro for 6 days and then activated by addition of LPS.
Supernatants were collected after 16 h of culture and filtered.
Isolated airway resident lymphocytes were then cultured over-
night in this conditioned media or in fresh media supplemented
with recombinant IL-18 andor IL-12. Supernatants from DCs
activated with LPS induced significant production of IFN- by
CD8 T cells, as did the cytokines IL-18 and IL-12 (Fig. 6c).
However, supernatant from resting DCs did not induce IFN-
production by the effector memory CD8 T cells (Fig. 6c). We
also found that the in vitro-cultured CD8 T cells described in
Fig. 5 responded to these stimuli in a comparable manner to the
influenza-induced effector memory CD8 T cells (data not
shown). IL-18 is produced by a variety of cell types in response
to LPS (21), Fas ligand stimulation (22), or histamine (23).
Furthermore, human macrophages have been shown to secrete
IL-18 when infected in vitro with influenza A (24, 25). Thus, the
response of the innate immune system to pathogens or allergens
in the airways could be a potent source of IL-18, which may
stimulate tissue-resident memory CD8 T cells to produce
IFN- and result in a localized IFN- dominant cytokine milieu.
Of importance, such a milieu is likely to make the airways
refractory to Th2 responses, and indeed we have shown that
IFN- is directly responsible for inhibiting the development of
Th2-mediated airway inflammation. Of note, a minor population
of CD8 lymphocytes was also activated to produce IFN- by
these stimuli. Further analysis showed that this population of
cells was CD4 (Fig. 6c and data not shown). We consider it
likely that these cells may also play a role in the heterologous
immunity that protects against allergic airway inflammation;
however because of the small size of this cell population, their
role is likely to be secondary, but complementary, to the CD8
memory T cell response.
It was recently reported that the timing of respiratory syncytial
virus infection during development has distinct effects on sub-
sequent immune responses in mice (26). Indeed, experimental
and epidemiological observations lead to the hypothesis that
sites of infection, genetic predisposition, and the timing, type,
and severity of infections are key factors in determining the
development of asthma. The lung and airways may be imprinted
by their infection history and consequently strongly bias the
nature of subsequent immune responses. We provide evidence
that strengthens this hypothesis and indicates a key role for
peripheral tissue resident memory T cells in this process. In
summary, our data suggest that virus-specific memory CD8 T
cells resident in the airways can be activated in the absence of
specific antigen to produce IFN-, which suppresses subsequent
allergic immune responses. The key mechanism appears to be
local production of IFN-, which acts to reduce allergen-induced
infiltration and activation of CD4 T cells present within
the lung and airways and as a consequence markedly re-
duces infiltration of eosinophils and development of airways
hyperresponsiveness.
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